Leveraging a hybrid tumor-informed and tumor-agnostic ctDNA assay for optimal ctDNA-MRD detection: A real-world study in Southeast Asia. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results